BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

Overview | Financials
Company Name BioMarin Pharmaceutical Inc.
Symbol BMRN
Currency USD
Price 57.5
Market Cap 11,027,120,000
Dividend Yield 0%
52-week-range 52.93 - 94.85
Industry Biotechnology
Sector Healthcare
CEO Mr. Jean-Jacques Bienaime M.B.A., MBA
Website https://www.biomarin.com

An error occurred while fetching data.

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with

Related Stocks

Viatris Inc. logo

Viatris Inc.

VTRS

9.32 USD

Insulet Corporation logo

Insulet Corporation

PODD

301.05 USD

Bio-Techne Corporation logo

Bio-Techne Corporation

TECH

53.14 USD

Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNY

331.91 USD

Incyte Corporation logo

Incyte Corporation

INCY

68.45 USD

Henry Schein, Inc. logo

Henry Schein, Inc.

HSIC

74.67 USD

Financials

Numbers are in millions USD

Numbers are in millions USD